
0.9997 Delayed Data As of May 25 | ![]() Today’s Change | 0.94 Today|||52-Week Range 9.54 | -58.52% Year-to-Date |
The 3 analysts offering 12-month price forecasts for Corvus Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 8.00 and a low estimate of 3.50. The median estimate represents a +500.18% increase from the last price of 1.00.
The current consensus among 3 polled investment analysts is to Buy stock in Corvus Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.